Search the Archive

Medicine: Depo-Provera #583821

NBC Evening News for Thursday, Oct 29, 1992
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws. For any such use, please visit NBC NEWS Archives XPRESS.

(Studio: Tom Brokaw) Report introduced.

(New York: Robert Bazell) Approval by the FDA (Food and Drug Administration) of the controversial long-term contraceptive drug Depo-Provera that is manufactured by Upjohn featured. [FDA (Food and Drug Administration) Dr. Ruth MERKATZ, Alan Guttmacher Institution Dr. Jacqueline FOREST - comment.] The drug's side effects outlined. [Public Citizen Health Research Group Dr. Sidney WOLFE - opposes the drug.] Implications of the decision for American funding of the use of Depo-Provera in birth control clinics in Third World countries noted.

Bazell, Robert;
Brokaw, Tom

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.